TY - JOUR
T1 - Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III)
T2 - multicentre randomised phase 3 clinical trial
AU - COSGOD III study group
AU - Pichler, Gerhard
AU - Goeral, Katharina
AU - Hammerl, Marlene
AU - Perme, Tina
AU - Dempsey, Eugene M.
AU - Springer, Laila
AU - Lista, Gianluca
AU - Szczapa, Tomasz
AU - Fuchs, Hans
AU - Karpinski, Lukasz
AU - Bua, Jenny
AU - Avian, Alexander
AU - Law, Brenda
AU - Urlesberger, Berndt
AU - Buchmayer, Julia
AU - Kiechl-Kohlendorfer, Ursula
AU - Kornhauser-Cerar, Lilijana
AU - Schwarz, Christoph E.
AU - Gründler, Kerstin
AU - Stucchi, Ilaria
AU - Schwaberger, Bernhard
AU - Klebermass-Schrehof, Katrin
AU - Schmölzer, Georg M.
AU - Wolfsberger, Christina
AU - Baik-Schneditz, Nariae
AU - Bruckner, Marlies
AU - Binder-Heschl, Corinna
AU - Pfurtscheller, Daniel
AU - Martensen, Johann
AU - Höller, Nina
AU - Ziehenberger, Evelyn
AU - Mileder, Lukas
AU - Berger, Angelika
AU - Baumgartner, Sigrid
AU - Grill, Agnes
AU - Mayr, Michaela
AU - Rittenschober-Boehm, Judith
AU - Schneider, Michael
AU - Schreiner, Christina
AU - Griesmaier, Elke
AU - Neubauer, Vera
AU - Wöckinger, Peter
AU - Posod, Anna
AU - Marolt, Anja
AU - Dimnik, Ana
AU - Kurtovič, Vlasta Lubej
AU - Aisling, Garvey
AU - Panaviene, Jurate
AU - Healy, David
AU - Herlihy, Ita
N1 - Publisher Copyright:
© 2023 BMJ Publishing Group. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Objective To investigate whether monitoring of cerebral tissue oxygen saturation using near infrared spectroscopy in addition to routine monitoring combined with defined treatment guidelines during immediate transition and resuscitation increases survival without cerebral injury of premature infants compared with standard care alone. Design Multicentre, multinational, randomised controlled phase 3 trial. setting 11 tertiary neonatal intensive care units in six countries in Europe and in Canada. ParticiPants 1121 pregnant women (<32 weeks’ gestation) were screened prenatally. The primary outcome was analysed in 607 of 655 randomised preterm neonates: 304 neonates in the near infrared spectroscopy group and 303 in the control group. interventiOn Preterm neonates were randomly assigned to either standard care (control group) or standard care plus monitoring of cerebral oxygen saturation with a dedicated treatment guideline (near infrared spectroscopy group) during immediate transition (first 15 minutes after birth) and resuscitation. Main OutcOMe Measure The primary outcome, assessed using all cause mortality and serial cerebral ultrasonography, was a composite of survival without cerebral injury. Cerebral injury was defined as any intraventricular haemorrhage or cystic periventricular leukomalacia, or both, at term equivalent age or before discharge. results Cerebral tissue oxygen saturation was similar in both groups. 252 (82.9%) out of 304 neonates (median gestational age 28.9 (interquartile range 26.9-30.6) weeks) in the near infrared spectroscopy group survived without cerebral injury compared with 238 (78.5%) out of 303 neonates (28.6 (26.6-30.6) weeks) in the control group (relative risk 1.06, 95% confidence interval 0.98 to 1.14). 28 neonates died (near infrared spectroscopy group 12 (4.0%) v control group 16 (5.3%): relative risk 0.75 (0.33 to 1.70). cOnclusiOn Monitoring of cerebral tissue oxygen saturation in combination with dedicated interventions in preterm neonates (<32 weeks’ gestation) during immediate transition and resuscitation after birth did not result in substantially higher survival without cerebral injury compared with standard care alone. Survival without cerebral injury increased by 4.3% but was not statistically significant.
AB - Objective To investigate whether monitoring of cerebral tissue oxygen saturation using near infrared spectroscopy in addition to routine monitoring combined with defined treatment guidelines during immediate transition and resuscitation increases survival without cerebral injury of premature infants compared with standard care alone. Design Multicentre, multinational, randomised controlled phase 3 trial. setting 11 tertiary neonatal intensive care units in six countries in Europe and in Canada. ParticiPants 1121 pregnant women (<32 weeks’ gestation) were screened prenatally. The primary outcome was analysed in 607 of 655 randomised preterm neonates: 304 neonates in the near infrared spectroscopy group and 303 in the control group. interventiOn Preterm neonates were randomly assigned to either standard care (control group) or standard care plus monitoring of cerebral oxygen saturation with a dedicated treatment guideline (near infrared spectroscopy group) during immediate transition (first 15 minutes after birth) and resuscitation. Main OutcOMe Measure The primary outcome, assessed using all cause mortality and serial cerebral ultrasonography, was a composite of survival without cerebral injury. Cerebral injury was defined as any intraventricular haemorrhage or cystic periventricular leukomalacia, or both, at term equivalent age or before discharge. results Cerebral tissue oxygen saturation was similar in both groups. 252 (82.9%) out of 304 neonates (median gestational age 28.9 (interquartile range 26.9-30.6) weeks) in the near infrared spectroscopy group survived without cerebral injury compared with 238 (78.5%) out of 303 neonates (28.6 (26.6-30.6) weeks) in the control group (relative risk 1.06, 95% confidence interval 0.98 to 1.14). 28 neonates died (near infrared spectroscopy group 12 (4.0%) v control group 16 (5.3%): relative risk 0.75 (0.33 to 1.70). cOnclusiOn Monitoring of cerebral tissue oxygen saturation in combination with dedicated interventions in preterm neonates (<32 weeks’ gestation) during immediate transition and resuscitation after birth did not result in substantially higher survival without cerebral injury compared with standard care alone. Survival without cerebral injury increased by 4.3% but was not statistically significant.
UR - https://www.scopus.com/pages/publications/85147048232
U2 - 10.1136/bmj-2022-072313
DO - 10.1136/bmj-2022-072313
M3 - Article
C2 - 36693654
AN - SCOPUS:85147048232
SN - 0959-8146
VL - 380
JO - BMJ
JF - BMJ
M1 - e072313
ER -